Concepedia

Publication | Open Access

Everolimus for treatment of tuberous sclerosis complex‐associated neuropsychiatric disorders

DOIFull Paper Access

131

Citations

41

References

2017

Year

Darcy A. Krueger, Anjali Sadhwani, Anna W. Byars, Petrus J. de Vries, David Neal Franz, Vicky Whittemore, Rajna Filip‐Dhima, Donna S. Murray, Kush Kapur, Mustafa Şahin
Annals of Clinical and Translational Neurology

Abstract

While safe, oral everolimus administered once daily for 6 months did not significantly improve neurocognitive functioning or behavior in children with TSC.

References

YearCitations

Page 1